is a biologist by training with a focus on molecular biology. After joining Dr. Regenold GmbH, she gained more than 18 years of experience in drug regulatory affairs and used her scientific and clinical expertise to develop strategic solutions for clinical development projects. For more than 10 years, she has supported CE plus GmbH in the preparation of clinical documentation that meets the legal requirements of EU regulations (MEDDEV 2.7.1, Medical Device Directive, Medical Device Regulation) for successful CE marking in Europe. Currently, it is responsible for the preparation of clinical evaluations and the tracking and maintenance of post-marketing surveillance of medical devices.